ภาพรวม
พัฒนาความเป็นอยู่ของผู้ป่วยด้วยนวัตกรรม
Focus on therapy areas with a high medical need
In its internal research for active ingredients, Bayer Schering Pharma concentrates on four core areas: Oncology, Cardiology, Women´s Healthcare, and Diagnostic Imaging. With new approaches in cancer therapy, cardiovascular diseases, gynecological therapies, and molecular imaging, we aim to become the innovation leader in these areas.
Strong pipeline in all business areas
While the early search for active ingredients is concentrated on four core areas, the clinical development of new products and the further development of marketed products is driven across all business areas. In addition to in-licensing, product accompanying development plays a significant role: it aims at identifying an active ingredient's additional potential in other indication areas, thus extending its range of application. This includes improving existing formulations and administration forms.
